|Articles|March 9, 2021

Biologics Contract Development and Manufacturing Services

Contract development and manufacturing (CDMO) services with support for mammalian, microbial, viral, plasma, and gene therapy.

Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Since 1998, Emergent BioSolutions has been a go-to source for solving some of the most complex and critical challenges in public health. From initial R&D and clinical studies to formulation, manufacturing and packaging, our experienced CDMO team at Emergent is ready to serve as your trusted guide from molecule to market.

Emergent BioSolutions
www.emergentcdmo.com


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.